Overview
InsureMe is a technology-enabled insurance broker that lets customers compare and buy personal, travel, life and health insurance from partner insurers. The most important recent operating change is that the September quarter produced less profit than the preceding quarter despite higher revenue, making the durability of the platform's earnings the central issue.
Price performance
At LKR 2,192 on 12 November 2026, the share had gained 62.4% over six months while the ASPI fell 3.3%. The price sat 61.9% of the way from its 52-week low to high, so it remained well above the bottom of its annual trading range. Volatility and trading volume were both above their own recent norms.
Liquidity is exceptionally limited: median daily turnover was LKR 28,000 over the last 60 sessions, and a LKR 1 million order is more than everything that trades on a typical day (3572% of it). Three-year drawdown history is unavailable.
Valuation
The P/E of 57.2 times means the market price equals 57.2 rupees for every rupee of trailing earnings, placing it at the 88th percentile among sector peers with usable P/E data. The P/B of 17.9 times means paying 17.9 rupees for each rupee of net assets, the highest reading in the peer set.
The audited return on equity of 35.7% helps explain why the share trades above book value, but not the full valuation gap. Across the CSE, the company scores 9 of 100 on price against book value and earnings, placing it in the Overvalued band. There is no recent dividend on record, and the company's own valuation history is too short for a like-for-like comparison.
News and sentiment
Direct company coverage is thin, with one material and neutral article in the past 90 days. The company declared a 1:100 share subdivision on 11 November 2026; the filing describes the terms, but the ex-date has not been set and no arithmetic should be inferred from the notice.
Financials
The September 2026 quarter generated revenue of LKR 162 million and net profit of LKR 9 million. Revenue was higher than in the June quarter, but profit was lower, meaning the additional sales converted less effectively into earnings.
Gross margin was 38.5% and net margin was 5.5%; operating margin was not supplied in the latest filing. The supplied filings do not provide a comparable year-ago quarter, so year-on-year margin comparisons cannot be made. Equity was LKR 251 million, with 2.1 million shares outstanding, unchanged from the latest balance-sheet count.
Risks
The most immediate practical risk is liquidity. A LKR 1 million trade is more than an entire typical trading session, so building or exiting even a modest position depends on scarce market turnover rather than a deep order flow.
Balance-sheet leverage is the next consideration. Total liabilities were 0.95 times equity at September 2026, meaning liabilities, including the funding items used in insurance and finance businesses, were equivalent to 95 cents for every rupee of equity. Total debt was LKR 62 million, while cash was LKR 136 million. The pending subdivision will mechanically alter per-share presentation when effective, without changing the company's underlying earning power.
Outlook
As at 12 November 2026, the next material operating evidence is the December 2026 interim quarter, expected to be filed between 4 and 14 February 2027. It will show whether the September reduction in profit was a one-quarter movement or persists into the next reporting period.
The announced 1:100 subdivision is not yet dated; as at the report date, its estimated ex-date window is 12 December 2026 to 31 January 2027. It changes the share denomination and per-share figures, not the underlying business. Insurance-sector news offers little company-specific guidance, although the sector backdrop notes changing bond yields and motor-claim cost conditions.